Avid Bioservices, Inc. (CDMO) financial statements (2020 and earlier)

Company profile

Business Address 2642 MICHELLE DRIVE, SUITE 200
TUSTIN, CA 92780
State of Incorp. DE
Fiscal Year End April 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

1/31/2020
TTM
4/30/2019
4/30/2018
4/30/2017
4/30/2016
4/30/2015
4/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31324247616877
Cash and cash equivalents31324247616877
Receivables10748341
Inventory, net of allowances, customer advances and progress billings10716331676
Inventory10716331676
Prepaid expense 111   
Other undisclosed current assets745 111
Total current assets:57516889828186
Noncurrent Assets
Operating lease, right-of-use asset20
Property, plant and equipment2726262424152
Restricted cash and investments  111  
Other noncurrent assets0004222
Other undisclosed noncurrent assets01     
Total noncurrent assets:4827282927175
TOTAL ASSETS:10578961181099791
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities88416221911
Accounts payable54268102
Accrued liabilities   5844
Employee-related liabilities3436654
Deferred revenue26
Debt1     (0)
Disposal group, including discontinued operation  5    
Deferred revenue and credits 291075
Customer advances and deposits 1724116
Contract with customer, liability15
Other liabilities1111101
Other undisclosed current liabilities  28   0
Total current liabilities:37233863583722
Noncurrent Liabilities
Long-term debt and lease obligation220     
Capital lease obligations0     
Operating lease, liability22
Liabilities, other than long-term debt 222111
Deferred revenue and credits 2110
Deferred rent credit 22
Other liabilities      0
Total noncurrent liabilities:22222111
Total liabilities:58254065593823
Stockholders' equity
Stockholders' equity attributable to parent47535654505968
Preferred stock0000000
Common stock0000000
Additional paid in capital613614615591559512471
Accumulated deficit(566)(561)(559)(537)(509)(454)(403)
Total stockholders' equity:47535654505968
TOTAL LIABILITIES AND EQUITY:10578961181099791

Income statement (P&L) ($ in millions)

1/31/2020
TTM
4/30/2019
4/30/2018
4/30/2017
4/30/2016
4/30/2015
4/30/2014
Revenues64545458452722
Revenue, net 58452722
Cost of revenue(55)(46)(57)(38)(23)(16)(13)
Cost of goods and services sold   (38)(23)(16)(13)
Other undisclosed gross profit    (0)(0)(0)
Gross profit:97(3)1921119
Operating expenses(15)(13)(16)(48)(78)(62)(45)
Other operating income (expense), net   (0)(0)00
Other expenses   (0)(0)  
Other undisclosed operating income (loss)  (1)00(0)(0)
Operating loss:(6)(6)(21)(28)(56)(50)(36)
Interest and debt expense     (0)(0)
Loss from continuing operations before equity method investments, income taxes:(6)(6)(21)(28)(56)(51)(36)
Other undisclosed income from continuing operations before income taxes000    
Loss from continuing operations before income taxes:(6)(5)(21)(28)(56)(51)(36)
Income tax benefit00   2215
Loss from continuing operations:(6)(5)(21)(28)(56)(29)(21)
Income (loss) from discontinued operations01(1)    
Net loss:(6)(4)(22)(28)(56)(29)(21)
Other undisclosed net income (loss) attributable to parent0  01(21)(15)
Net loss attributable to parent:(5)(4)(22)(28)(56)(50)(35)
Preferred stock dividends and other adjustments(5)(5)(5)(5)(4)40
Other undisclosed net loss available to common stockholders, basic     (7)(1)
Net loss available to common stockholders, diluted:(11)(9)(26)(33)(60)(54)(36)

Comprehensive Income ($ in millions)

1/31/2020
TTM
4/30/2019
4/30/2018
4/30/2017
4/30/2016
4/30/2015
4/30/2014
Net loss:(6)(4)(22)(28)(56)(29)(21)
Comprehensive loss:(6)(4)(22)(28)(56)(29)(21)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0  01(21)(15)
Comprehensive loss, net of tax, attributable to parent:(5)(4)(22)(28)(56)(50)(35)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: